Ronan Lev, MD
Urology · Saint Peters, MONPI 1871602573
Payments from drug & device makers
Across 186 payments — averaging $42.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teleflex LLC$2K
- Neotract Inc.$1K
- Boston Scientific$516
- Astellas Pharma US Inc$468
- Sumitomo Pharma America, Inc.$390
- Ferring Pharmaceuticals Inc.$367
- plus $3K from 30 others
What the payments were for
- Travel & lodging$1,29717%
- Food & beverage$6,54483%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teleflex LLC | 23 | $2,310 |
| Neotract Inc. | 12 | $1,018 |
| Boston Scientific | 7 | $516 |
| Astellas Pharma US Inc | 30 | $468 |
| Sumitomo Pharma America, Inc. | 26 | $390 |
| Ferring Pharmaceuticals Inc. | 8 | $367 |
| Accord Healthcare, Inc. | 5 | $338 |
| Urogen Pharma, Inc. | 5 | $308 |
| Johnson & Johnson | 9 | $268 |
| Myriad Genetic Laboratories, Inc. | 9 | $262 |
| Procept Biorobotics Corporation | 3 | $243 |
| Cook Medical LLC | 1 | $173 |
| Olympus America Inc. | 2 | $163 |
| Janssen Scientific Affairs, LLC | 1 | $125 |
| Laborie Medical Technologies Corp. | 5 | $69 |
| Acerus Pharmaceuticals Corporation | 3 | $66 |
| AbbVie | 4 | $63 |
| KARL Storz Endoscopy-america | 1 | $63 |
| Telix Pharmaceuticals | 1 | $61 |
| Progenics Pharmaceuticals, Inc. | 3 | $60 |
| Antares Pharma, Inc. | 3 | $54 |
| Myovant Sciences Inc. | 2 | $49 |
| Tolmar, Inc. | 3 | $46 |
| Merck | 3 | $46 |
| Heron Therapeutics, Inc. | 2 | $42 |
| Blue Earth Diagnostics | 2 | $38 |
| Bayer | 2 | $38 |
| Medtronic | 1 | $34 |
| Mission Pharmacal Company | 2 | $33 |
| Pfizer | 2 | $30 |
| Novartis | 1 | $25 |
| Amgen | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Convatec Inc. | 1 | $13 |
| Urovant Sciences Inc | 1 | $12 |
| 180 Medical, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UroLift$2,347
- UroLift System$418
- ADSTILADRIN$259
- ZUSDURI$246
- Barrigel$192
- AQUABEAM SYSTEM$190
- Cook$173
- SpaceOAR VUE System - 10mL$170
- RYBREVANT$136
- CARVYKTI$136
- iTIND System$129
- Erleada$125
- Prolaris$108
- CAMCEVI$108
- LithoVue$102
- GENERAL PAIN MANAGEMENT$102
How this compares
$7,841 in reported general payments places this provider in the 70th percentile of 250 urology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 151 | $90,972 |
| OrgovyxRelugolix | 24 | $63,748 |
| GemtesaVibegron | 19 | $14,342 |
| Tamsulosin Hcl | 495 | $5,467 |
| Trospium Chloride | 103 | $2,664 |
| Solifenacin Succinate | 30 | $1,913 |
| Finasteride | 136 | $1,555 |
| Trospium Chloride ErTrospium Chloride | 21 | $1,301 |
| Oxybutynin Chloride | 47 | $741 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 48 | $611 |
| Oxybutynin Chloride ErOxybutynin Chloride | 34 | $296 |
| Dutasteride | 22 | $232 |
| NitrofurantoinNitrofurantoin Macrocrystal | 13 | $186 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 41 | $183 |
| Tramadol Hcl | 24 | $38 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $468 | $90,972151 claims |
| Sumitomo Pharma America, Inc.Orgovyx, Gemtesa | $390 | $78,09043 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 250 urology providers in Missouri.
Other urology in Saint Peters
- Majdee IslamSaint Peters$66K
- Jeffrey GlaserSaint Peters$39K
- Kimberly BerniSaint Peters$14K
- Travis BullockSaint Louis$751K
- Michael JohnsonSaint Louis$471K
- Gregory AuffenbergSaint Louis$468K
- Gerald AndrioleSaint Louis$308K
- Hing LaiSaint Louis$173K
- Samuel KuykendallKansas City$141K
- Donald NeffKansas City$141K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.